Ken Belotsky
Investing Profile
Sweet spot: $1M
Range: $500K–$3M
Sector and stage focus
- Series B: BioTech
- general: Israel, Investors who were founders, Canada
- Series A: BioTech
- Seed: BioTech
Recent investments by Ken Belotsky
Ken Belotsky has 6 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Delix Therapeutics | Series A | Sep 2021 | $70M |
| Gilgamesh Pharmaceuticals | series B | May 2022 | $1 |
| ATAI Life Sciences | Series B | Mar 2019 | $43M |
| Mindstate Design Labs | Seed Round | Feb 2022 | $12M |
| Beckley Psytech | Series B | Aug 2021 | £58M |
| Small Pharma | Seed Round | Apr 2017 | £830K |
Frequent co-investors
Ken Belotsky has co-invested with: Eric Brook.
Is Ken Belotsky a fit for your round?
Upload your pitch deck and see whether Ken Belotsky appears in your top 20 matches.
Find investors for your deck